Probi

Probi's Annual Report and Sustainability Report for 2023 are now available on the company website, www.probi.com under Investor Relations: https://www.probi.com/investor-relations/financial-reports/

This information is information that Probi AB is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication at 12.10 CET on 25 March 2024.

For further information, please contact:

Per Lindblad, CFO, Probi
Phone +46 46 286 89 41, E-mail: per.lindblad@probi.com

ABOUT PROBI
Probi^® is a global Group that focuses exclusively on research, manufacturing and delivery of probiotics in dietary supplements and food. The company has expertise in managing live bacteria from research through all stages of the manufacturing process and is dedicated to making the health-promoting benefits of probiotics available to people around the world. Since the company was founded in 1991 at Lund University in Sweden, Probi has expanded its operations to more than 40 markets and holds more than 400 patents worldwide. Probi had sales of SEK 628 m in 2023. Probi's shares are listed on Nasdaq Stockholm, Mid-cap, and there were around 3,400 shareholders on December 31, 2023.